Long-term Follow-up of Fingolimod Phase II Study Patients
NCT02307838
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
177
Enrollment
INDUSTRY
Sponsor class
Conditions
Multiple Sclerosis, Relapsing Forms of Multiple Sclerosis
Interventions
OTHER:
Assessments arm
Sponsor
Novartis Pharmaceuticals